Logo ofBasma Adeem Medical Co.
Basma Adeem Medical Co. issued today, Dec. 25, the prospectus to list four million shares on the Nomu-Parallel Market. 
The offered shares represent 25% of the company’s pre-IPO of SAR 16 million (divided into 16 million shares) at SAR 1 per share. These shares also represent 20% of post-IPO capital amounting to SAR 20 million.
The IPO, limited to qualified investors according to the CMA regulations, will run for six working days from Jan. 15-19.
In Oct. 28, the Capital Market Authority (CMA) approved the company’s application to float its shares on Nomu.
Basma Adeem Medical was founded in 2012 in Riyadh as a limited liability company before becoming a closed joint-stock Saudi company.
The company specializes in dentistry, offering treatment and cosmetic services. Its commercial registration lists additional activities, including specialty medical complexes, day surgery centers, medical clinics, and managing the operations of these facilities.
Company Profile
Company
Basma Adeem Medical Co.
Market
Nomu-Parallel Market
Core Activities
Providing management consulting services
Capital before IPO
SAR 16 mln
Number of Shares
16 mln
Capital after IPO
SAR 20 mln
New Number of Shares
20 mln
Par Value
SAR 1 per share
IPO Summary
Issue Percentage
20% of post-increase capital (25% of pre-IPO capital)
Offered Shares
4 mln
IPO Minimum Limit
100 shares
IPO Maximum Limit
999900 shares
Offer Period
five working days from Jan. 13-19
Final Allocation
Jan. 22, 2025
Surplus Refund (If any)
Jan. 26, 2025
Company Shareholders
Shareholder
Pre-IPO
Post-IPO
Number of Shares
(‘000)
Ownership (%)
Number of Shares
(‘000)
Ownership (%)
Abdullah Al-Qadeeri
4030.03
25.19%
4030.03
20.15%
Mohammed Al-Buardi
3664.73
22.90%
3664.73
18.32%
Talal Al-Nassar
2748.88
17.18%
2748.88
13.74%
Mohammed Al-Sarhan
2015.67
12.60%
2015.67
10.08%
Treasury Shares
1600.00
10.00%
1600.00
8.00%
Sahmain Investment Company
587.09
3.67%
587.09
2.94%
Farraj Al-Balawi
360.00
2.25%
360.00
1.80%
Nora Al-Sunaidi
288.00
1.80%
288.00
1.44%
Ibrahim Al-Oqeili
216.00
1.35%
216.00
1.08%
Abdulaziz Al-Bulaihis
144.00
0.90%
144.00
0.72%
Yazid Al-Buardi
86.40
0.54%
86.40
0.43%
Muteb Al-Qadeeri
86.40
0.54%
86.40
0.43%
Khalid Al-Nassar
86.40
0.54%
86.40
0.43%
Nora Al-Sahli
86.40
0.54 %
86.40
0.43%
Qualified Investors
—
—
4000
20.00%
Total
20000
100%
21000
100%
Additional Information
Financial Advisor Lead Manager
Yaqeen Capital
Receiving Entities
Alinma Investment – Al Rajhi Capital – SNB Capital – BSF Capital – Riyad Capital – ANB Capital – Alistithmar Capital – Albilad Capital – AlJazira Capital – GIB Capital – Alkhabeer Capital – SAB Invest – Sahm Capital – Derayah Financial
Logo ofBasma Adeem Medical Co.
Basma Adeem Medical Co. issued today, Dec. 25, the prospectus to list four million shares on the Nomu-Parallel Market.
The offered shares represent 25% of the company’s pre-IPO of SAR 16 million (divided into 16 million shares) at SAR 1 per share. These shares also represent 20% of post-IPO capital amounting to SAR 20 million.
The IPO, limited to qualified investors according to the CMA regulations, will run for six working days from Jan. 15-19.
In Oct. 28, the Capital Market Authority (CMA) approved the company’s application to float its shares on Nomu.
Basma Adeem Medical was founded in 2012 in Riyadh as a limited liability company before becoming a closed joint-stock Saudi company.
The company specializes in dentistry, offering treatment and cosmetic services. Its commercial registration lists additional activities, including specialty medical complexes, day surgery centers, medical clinics, and managing the operations of these facilities.
Company Profile
Company
Basma Adeem Medical Co.
Market
Nomu-Parallel Market
Core Activities
Providing management consulting services
Capital before IPO
SAR 16 mln
Number of Shares
16 mln
Capital after IPO
SAR 20 mln
New Number of Shares
20 mln
Par Value
SAR 1 per share
IPO Summary
Issue Percentage
20% of post-increase capital (25% of pre-IPO capital)
Offered Shares
4 mln
IPO Minimum Limit
100 shares
IPO Maximum Limit
999900 shares
Offer Period
five working days from Jan. 13-19
Final Allocation
Jan. 22, 2025
Surplus Refund (If any)
Jan. 26, 2025
Company Shareholders
Shareholder
Pre-IPO
Post-IPO
Number of Shares
(‘000)
Ownership (%)
Number of Shares
(‘000)
Ownership (%)
Abdullah Al-Qadeeri
4030.03
25.19%
4030.03
20.15%
Mohammed Al-Buardi
3664.73
22.90%
3664.73
18.32%
Talal Al-Nassar
2748.88
17.18%
2748.88
13.74%
Mohammed Al-Sarhan
2015.67
12.60%
2015.67
10.08%
Treasury Shares
1600.00
10.00%
1600.00
8.00%
Sahmain Investment Company
587.09
3.67%
587.09
2.94%
Farraj Al-Balawi
360.00
2.25%
360.00
1.80%
Nora Al-Sunaidi
288.00
1.80%
288.00
1.44%
Ibrahim Al-Oqeili
216.00
1.35%
216.00
1.08%
Abdulaziz Al-Bulaihis
144.00
0.90%
144.00
0.72%
Yazid Al-Buardi
86.40
0.54%
86.40
0.43%
Muteb Al-Qadeeri
86.40
0.54%
86.40
0.43%
Khalid Al-Nassar
86.40
0.54%
86.40
0.43%
Nora Al-Sahli
86.40
0.54 %
86.40
0.43%
Qualified Investors
—
—
4000
20.00%
Total
20000
100%
21000
100%
Additional Information
Financial Advisor Lead Manager
Yaqeen Capital
Receiving Entities
Alinma Investment – Al Rajhi Capital – SNB Capital – BSF Capital – Riyad Capital – ANB Capital – Alistithmar Capital – Albilad Capital – AlJazira Capital – GIB Capital – Alkhabeer Capital – SAB Invest – Sahm Capital – Derayah Financial
